Bambusa Therapeutics prices upsized initial public offering on Nasdaq
Clinical stage biopharmaceutical firm Bambusa Therapeutics priced its upsized initial public offering on the Nasdaq Stock Market under the ticker symbol BBTX to fund antibody development
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.